|
Arnold S. Freedman, MD received his MD in 1979 and training in internal medicine at the University of Massachusetts Medical School. He then completed a fellowship in adult oncology at Dana Farber Cancer institute and studied cell surface antigens of normal and malignant B lymphocytes. Since 1985 Dr. Freedman has continued laboratory studies of normal and malignant B cells with a special interest in how normal and neoplastic microenvironments affect B cell function. His clinical research involves the development of new therapies for non-Hodgkin's lymphomas.
Dr. Freedman's research interests have focused on stem cell transplantation and the development of new therapies for non-Hodgkin's lymphoma. More recent efforts are in enhancing the effects of antibody based therapies and understanding how the tumor microenvironment can be manipulated in the treatment of lymphomas.
|
